ML365 is a selective inhibitor of the TASK-1 potassium channel, which has potential applications in the field of biomedical research and therapeutic development. It is primarily used in studies to investigate the role of TASK-1 channels in various physiological processes, such as the regulation of neuronal excitability, cardiac function, and respiratory control. By blocking TASK-1 channels, ML365 helps researchers understand their contribution to conditions like arrhythmias, sleep apnea, and certain neurological disorders. Additionally, it serves as a tool for exploring potential therapeutic targets for diseases where TASK-1 channels are implicated. Its specificity makes it valuable for dissecting the functions of TASK-1 channels in complex biological systems.